Abstract A1R, A2AR, A2BR, and A3R adenosine receptors comprise a G protein-coupled receptor (GPCR) subfamily that regulates many bodily processes. Subtype-selective agonists potentially treat inflammatory and ischemic conditions. The dual A2AR/A2BR agonist MRS3997 protects post-ischemic brain during prolonged inflammation. However, despite known A2AR and A2BR structural and pharmacological differences, MRS3997’s activation mechanisms at A2AR/A2BR remain unclear.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile